by Mike Masnick
Mon, Mar 26th 2012 8:03pm
As we expected, following the Supreme Court's excellent rejection of medical diagnostic patents, it's now set aside the appeals court's ruling upholding gene patents, and asked the appeals court to review the case in light of its ruling last week. Again, this is not a surprise, but it's good that the court so quickly recognized that the two cases have similar issues, and that the appeals court ought to revisit the Myriad (gene patents) ruling so quickly. Hopefully, CAFC (the appeals court in question) will come to its senses and recognize that you can't patent genes. Either way, no matter what CAFC decides, expect that to also be appealed right back to the Supreme Court.
If you liked this post, you may also be interested in...
- Yes, The Appeals Court Got Basically Everything Wrong In Deciding API's Are Covered By Copyright
- Why Patent Trolls Love East Texas... And Why Congress Needs To Fix It
- Could A Hedge Fund Manager Trying To Short Stocks Of Pharma Companies With Bad Patents Derail Patent Reform?
- Myriad Genetics Finally Gives Up Its Gene Patent Fight... Just As The Patent Office Opens The Doors Up To More Gene Patents
- Myriad Loses Again: Patents On Genetic Testing Ruled Invalid